MedTrace Logo

Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

NCT04657146 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-11-12

No results posted yet for this study

Summary

The main goal of this study is to provide foundational data to drive translational approaches for an entirely novel category of immunotherapy.

Conditions

Interventions

OTHER

Biorepository

Tumor collection (\> 1cm3): Intraoperatively Peripheral blood collection: * Intraoperatively (60mL +/- 5mL) * Post-resection (30mL +/- 5mL) * Post- standard of care treatment (30mL +/- 5 mL) Bone marrow aspiration: * Intraoperatively (10mL +/- 5 mL) * Post-resection (5mL +/- 5 mL) * Post- standard of care treatment (5mL +/- 5 mL)

Sponsors & Collaborators

Principal Investigators

  • Anoop Patel, M.D. · Duke University

  • Katayoun Ayasoufi, Ph.D. · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2027-11-01
Completion
2028-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657146 on ClinicalTrials.gov